1
|
Alkholief M, Kalam MA, Raish M, Ansari MA, Alsaleh NB, Almomen A, Ali R, Alshamsan A. Topical Sustained-Release Dexamethasone-Loaded Chitosan Nanoparticles: Assessment of Drug Delivery Efficiency in a Rabbit Model of Endotoxin-Induced Uveitis. Pharmaceutics 2023; 15:2273. [PMID: 37765242 PMCID: PMC10537057 DOI: 10.3390/pharmaceutics15092273] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2023] [Revised: 07/14/2023] [Accepted: 08/25/2023] [Indexed: 09/29/2023] Open
Abstract
Uveitis is an ocular illness that if not treated properly can lead to a total loss of vision. In this study, we evaluated the utility of HA-coated Dexamethasone-sodium-phosphate (DEX)-chitosan nanoparticles (CSNPs) coated with hyaluronic acid (HA) as a sustained ocular delivery vehicle for the treatment of endotoxin-induced-uveitis (EIU) in rabbits. The CSNPs were characterized for particle size, zeta potential, polydispersity, surface morphology, and physicochemical properties. Drug encapsulation, in vitro drug release, and transcorneal permeation were also evaluated. Finally, eye irritation, ocular pharmacokinetics, and pharmacodynamics were in vivo. The CSNPs ranged from 310.4 nm and 379.3 nm pre-(uncoated) and post-lyophilization (with HA-coated), respectively. The zeta potentials were +32 mV (uncoated) and -5 mV (HA-uncoated), while polydispersity was 0.178-0.427. Drug encapsulation and loading in the CSNPs were 73.56% and 6.94% (uncoated) and 71.07% and 5.54% (HA-coated), respectively. The in vitro DEX release over 12 h was 77.1% from the HA-coated and 74.2% from the uncoated NPs. The physicochemical properties of the CSNPs were stable over a 3-month period when stored at 25 °C. Around a 10-fold increased transcorneal-flux and permeability of DEX was found with HA-CSNPs compared to the DEX-aqueous solution (DEX-AqS), and the eye-irritation experiment indicated its ocular safety. After the ocular application of the CSNPs, DEX was detected in the aqueous humor (AH) till 24 h. The area under the concentrations curve (AUC0-24h) for DEX from the CSNPs was 1.87-fold (uncoated) and 2.36-fold (HA-coated) higher than DEX-AqS. The half-life (t1/2) of DEX from the uncoated and HA-coated NPs was 2.49-and 3.36-fold higher, and the ocular MRT0-inf was 2.47- and 3.15-fold greater, than that of DEX-AqS, respectively. The EIU rabbit model showed increased levels of MPO, TNF-α, and IL-6 in AH. Topical DEX-loaded CSNPs reduced MPO, TNF-α, and IL-6 levels as well as inhibited NF-κB expression. Our findings demonstrate that the DEX-CSNPs platform has improved the delivery properties and, hence, the promising anti-inflammatory effects on EIU in rabbits.
Collapse
Affiliation(s)
- Musaed Alkholief
- Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (M.A.K.); (M.R.); (R.A.)
| | - Mohd Abul Kalam
- Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (M.A.K.); (M.R.); (R.A.)
| | - Mohammad Raish
- Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (M.A.K.); (M.R.); (R.A.)
| | - Mushtaq Ahmad Ansari
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (M.A.A.); (N.B.A.)
| | - Nasser B. Alsaleh
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (M.A.A.); (N.B.A.)
| | - Aliyah Almomen
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia;
| | - Raisuddin Ali
- Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (M.A.K.); (M.R.); (R.A.)
| | - Aws Alshamsan
- Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (M.A.K.); (M.R.); (R.A.)
| |
Collapse
|
2
|
Self-Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment. Pharmaceutics 2022; 14:pharmaceutics14112461. [PMID: 36432652 PMCID: PMC9695327 DOI: 10.3390/pharmaceutics14112461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2022] [Revised: 11/04/2022] [Accepted: 11/12/2022] [Indexed: 11/17/2022] Open
Abstract
Triple-negative breast cancer (TNBC) has been listed as one of the most fatal diseases, and no effective targeting treatment is clinically available. Although CD44-targeting hyaluronic acid (HA) has been utilized as targeting ligands in many studies, no facile ways have been developed through HA self-assembly at the nanoparticle surface. Herein, we reported N-isopropylacrylamide-grafted chitosan-based nanoparticles self-assembling with HA (HA-NPs) through electrostatic forces and loaded with curcumin (CUR). The HA-NPs displayed pH-responsive properties due to the chemical modification of chitosan, and the preparation process was optimized by central composite design-response surface methodology. HA anchorage confers the vehicle with tumor-targeting capability. HA-NPs displayed more robust effects of inhibiting TNBC primary tumor growth than free CUR and a plain counterpart but without increased systemic cytotoxicity. In addition, in vivo pharmacokinetic studies showed that HA-NPs significantly increased the in vivo residence time of free CUR and improved the bioavailability of CUR. These findings suggested that chitosan-based HA-NPs may provide a feasible and unique strategy to achieve CD44 targeting and enhance its efficacy in vivo for the treatment of advanced TNBC.
Collapse
|
3
|
Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate. Molecules 2022; 27:molecules27072326. [PMID: 35408724 PMCID: PMC9000411 DOI: 10.3390/molecules27072326] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2022] [Revised: 03/29/2022] [Accepted: 03/31/2022] [Indexed: 02/04/2023] Open
Abstract
This study investigates the development of topically applied non-invasive chitosan-nanoparticles (CSNPs) for ocular delivery of tedizolid phosphate (TZP) for the treatment of MRSA-related ocular and orbital infections. An ionic-gelation method was used to prepare TZP-encapsulated CSNPs using tripolyphosphate-sodium (TPP) as cross-linker. Particle characterization was performed by the DLS technique (Zeta-Sizer), structural morphology was observed by SEM. The drug encapsulation and loading were determined by the indirect method. In-vitro release was conducted through dialysis bags in simulated tear fluid (pH 7) with 0.25% Tween-80. Physicochemical characterizations were performed for ocular suitability of CSNPS. An antimicrobial assay was conducted on different strains of Gram-positive bacteria. Eye-irritation from CSNPs was checked in rabbits. Transcorneal flux and apparent permeability of TZP from CSNPs was estimated through excised rabbit cornea. Ionic interaction between the anionic and cationic functional groups of TPP and CS, respectively, resulted in the formation of CSNPs at varying weight ratios of CS/TPP with magnetic stirring (700 rpm) for 4 h. The CS/TPP weight ratio of 3.11:1 with 10 mg of TZP resulted in optimal-sized CSNPs (129.13 nm) with high encapsulation (82%) and better drug loading (7%). Release profiles indicated 82% of the drug was released from the TZP aqueous suspension (TZP-AqS) within 1 h, while it took 12 h from F2 to release 78% of the drug. Sustained release of TZP from F2 was confirmed by applying different release kinetics models. Linearity in the profile (suggested by Higuchi’s model) indicated the sustained release property CSNPs. F2 has shown significantly increased (p < 0.05) antibacterial activity against some Gram-positive strains including one MRSA strain (SA-6538). F2 exhibited a 2.4-fold increased transcorneal flux and apparent permeation of TZP as compared to TZP-AqS, indicating the better corneal retention. No sign or symptoms of discomfort in the rabbits’ eyes were noted during the irritation test with F2 and blank CSNPs, indicating the non-irritant property of the TZP-CSNPs. Thus, the TZP-loaded CSNPs have strong potential for topical use in the treatment of ocular MRSA infections and related inflammatory conditions.
Collapse
|
4
|
α1-Acid Glycoprotein-Decorated Hyaluronic Acid Nanoparticles for Suppressing Metastasis and Overcoming Drug Resistance Breast Cancer. Biomedicines 2022; 10:biomedicines10020414. [PMID: 35203623 PMCID: PMC8962395 DOI: 10.3390/biomedicines10020414] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Revised: 01/10/2022] [Accepted: 01/12/2022] [Indexed: 01/01/2023] Open
Abstract
Robust inflammation-suppressing nanoparticles based on α1-acid glycoprotein (AGP)-conjugated hyaluronic acid nanoparticles (AGP-HA NPs) were designed to regulate breast cancer cells’ sensitivity to chemotherapy and to suppress tumor metastasis. The successful conjugation between AGP and HA NPs was confirmed using FTIR, zeta potential, and UV–vis spectroscopy. In vitro studies on MCF-7 cells indicated the remarkable ability of AGP-HA NPs in suppressing migratory tumor ability by 79% after 24 h. Moreover, the efficacy study showed the high capability of AGP-HA NPs in modulating MDA-MB-231 cells and restoring cell sensitivity to the chemotherapeutic drug doxorubicin (DOX). Furthermore, the finding obtained by flow cytometry and confocal spectroscopy demonstrated that AGP-HA NPs enhanced DOX uptake/retention and aided it to reach cell nucleus within 4 h of incubation. Therefore, AGP-HA NPs represent a viable and effective treatment option to strengthen the anticancer effects of chemotherapeutic agents and potentially improve patients’ survival rates.
Collapse
|
5
|
CD44-Targeted Carriers: The Role of Molecular Weight of Hyaluronic Acid in the Uptake of Hyaluronic Acid-Based Nanoparticles. Pharmaceuticals (Basel) 2022; 15:ph15010103. [PMID: 35056160 PMCID: PMC8781203 DOI: 10.3390/ph15010103] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Revised: 01/11/2022] [Accepted: 01/13/2022] [Indexed: 02/01/2023] Open
Abstract
Nanotechnology offers advanced biomedical tools for diagnosis and drug delivery, stressing the value of investigating the mechanisms by which nanocarriers interact with the biological environment. Herein, the cellular response to CD44-targeted nanoparticles (NPs) was investigated. CD44, the main hyaluronic acid (HA) receptor, is widely exploited as a target for therapeutic purposes. HA NPs were produced by microfluidic platform starting from HA with different molecular weights (Mw, 280, 540, 820 kDa) by polyelectrolyte complexation with chitosan (CS). Thanks to microfluidic technology, HA/CS NPs with the same physical features were produced, and only the effects of HA Mw on CD44-overexpressing cells (human mesenchymal stem cells, hMSCs) were studied. This work provides evidence of the HA/CS NPs biocompatibility regardless the HA Mw and reveals the effect of low Mw HA in improving the cell proliferation. Special attention was paid to the endocytic mechanisms used by HA/CS NPs to enter hMSCs. The results show the notable role of CD44 and the pronounced effect of HA Mw in the NPs’ internalization. HA/CS NPs uptake occurs via different endocytic pathways simultaneously, and most notably, NPs with 280 kDa HA were internalized by clathrin-mediated endocytosis. Instead, NPs with 820 kDa HA revealed a greater contribution of caveolae and cytoskeleton components.
Collapse
|
6
|
Redox/pH-dual responsive functional hollow silica nanoparticles for hyaluronic acid-guided drug delivery. J IND ENG CHEM 2021. [DOI: 10.1016/j.jiec.2021.12.026] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
7
|
Plausible role of chitosan in drug and gene delivery against resistant breast cancer cells. Carbohydr Res 2021; 506:108357. [PMID: 34146935 DOI: 10.1016/j.carres.2021.108357] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2021] [Revised: 05/19/2021] [Accepted: 05/24/2021] [Indexed: 01/02/2023]
Abstract
Breast cancer is the highest global spread of invasive cancer in women. While significant progress has been made in breast cancer, diagnostic and therapeutic effective prevention and treatment options remain scarce. Concerning chitosan-based chemotherapeutic therapies, the studies reported cell migration resistance, improved drug absorption, membrane interaction and permeability, immune stimulating behavior, and extended in-vitro drug release. However, chitosan has been practically restricted mostly to unmodified forms. Targeted distribution is ensured by chitosan-based ligand conjugated carrier systems in conjunction with active moieties such as DNA, RNA, proteins, and therapeutic agents. The purpose of this context is to emphasize the efficient drug delivery to breast cancer cell lines using chitosan. Chitosan also exhibited excellent capabilities in gene packaging. For the interaction of bioactive molecules and the regulation of the drug release profile, chemical modification of chitosan is beneficial. This article discusses the various chitosan-based ligand conjugated carrier systems. From the studies reviewed it can be concluded that chitosan derivatives are promising materials for targeted and non-viral gene delivery in treatment of breast cancer.
Collapse
|
8
|
Midgley AC, Wei Y, Zhu D, Gao F, Yan H, Khalique A, Luo W, Jiang H, Liu X, Guo J, Zhang C, Feng G, Wang K, Bai X, Ning W, Yang C, Zhao Q, Kong D. Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy. J Am Soc Nephrol 2020; 31:2292-2311. [PMID: 32769144 DOI: 10.1681/asn.2019111160] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2019] [Accepted: 05/27/2020] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND Progressive fibrosis is the underlying pathophysiological process of CKD, and targeted prevention or reversal of the profibrotic cell phenotype is an important goal in developing therapeutics for CKD. Nanoparticles offer new ways to deliver antifibrotic therapies to damaged tissues and resident cells to limit manifestation of the profibrotic phenotype. METHODS We focused on delivering plasmid DNA expressing bone morphogenetic protein 7 (BMP7) or hepatocyte growth factor (HGF)-NK1 (HGF/NK1) by encapsulation within chitosan nanoparticles coated with hyaluronan, to safely administer multifunctional nanoparticles containing the plasmid DNA to the kidneys for localized and sustained expression of antifibrotic factors. We characterized and evaluated nanoparticles in vitro for biocompatibility and antifibrotic function. To assess antifibrotic activity in vivo, we used noninvasive delivery to unilateral ureteral obstruction mouse models of CKD. RESULTS Synthesis of hyaluronan-coated chitosan nanoparticles containing plasmid DNA expressing either BMP7 or NGF/NKI resulted in consistently sized nanoparticles, which-following endocytosis driven by CD44+ cells-promoted cellular growth and inhibited fibrotic gene expression in vitro. Intravenous tail injection of these nanoparticles resulted in approximately 40%-45% of gene uptake in kidneys in vivo. The nanoparticles attenuated the development of fibrosis and rescued renal function in unilateral ureteral obstruction mouse models of CKD. Gene delivery of BMP7 reversed the progression of fibrosis and regenerated tubules, whereas delivery of HGF/NK1 halted CKD progression by eliminating collagen fiber deposition. CONCLUSIONS Nanoparticle delivery of HGF/NK1 conveyed potent antifibrotic and proregenerative effects. Overall, this research provided the proof of concept on which to base future investigations for enhanced targeting and transfection of therapeutic genes to kidney tissues, and an avenue toward treatment of CKD.
Collapse
Affiliation(s)
- Adam C Midgley
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China .,Rongxiang Xu Center for Regenerative Life Science, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China
| | - Yongzhen Wei
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
| | - Dashuai Zhu
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
| | - Fangli Gao
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China.,Rongxiang Xu Center for Regenerative Life Science, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China
| | - Hongyu Yan
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
| | - Anila Khalique
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China.,Rongxiang Xu Center for Regenerative Life Science, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China
| | - Wenya Luo
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China.,Rongxiang Xu Center for Regenerative Life Science, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China
| | - Huan Jiang
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
| | - Xiangsheng Liu
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China.,Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
| | - Jiasen Guo
- Department of Genetics and Cellular Biology, College of Life Sciences, Nankai University, Tianjin, China
| | - Chuangnian Zhang
- Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
| | - Guowei Feng
- Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Kai Wang
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
| | - Xueyuan Bai
- Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, Beijing, China.,State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing, China
| | - Wen Ning
- Department of Genetics and Cellular Biology, College of Life Sciences, Nankai University, Tianjin, China
| | - Chao Yang
- Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
| | - Qiang Zhao
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
| | - Deling Kong
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China .,Rongxiang Xu Center for Regenerative Life Science, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China.,Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
| |
Collapse
|
9
|
On the Formation and Stability of Chitosan/Hyaluronan-Based Complex Coacervates. MOLECULES (BASEL, SWITZERLAND) 2020; 25:molecules25051071. [PMID: 32121005 PMCID: PMC7179103 DOI: 10.3390/molecules25051071] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/28/2020] [Revised: 02/18/2020] [Accepted: 02/24/2020] [Indexed: 02/07/2023]
Abstract
This contribution is aimed at extending our previous findings on the formation and stability of chitosan/hyaluronan-based complex coacervates. Colloids are herewith formed by harnessing electrostatic interactions between the two polyelectrolytes. The presence of tiny amounts of the multivalent anion tripolyphosphate (TPP) in the protocol synthesis serves as an adjuvant “point-like” cross-linker for chitosan. Hydrochloride chitosans at different viscosity average molar mass, Mv¯, in the range 10,000–400,000 g/mol, and fraction of acetylated units, FA, (0.16, 0.46 and 0.63) were selected to fabricate a large library of formulations. Concepts such as coacervate size, surface charge and homogeneity in relation to chitosan variables are herein disclosed. The stability of coacervates in Phosphate Buffered Saline (PBS) was verified by means of scattering techniques, i.e., Dynamic Light Scattering (DLS) and Small-Angle X-ray Scattering (SAXS). The conclusions from this set of experiments are the following: (i) a subtle equilibrium between chitosan FA and Mv¯ does exist in ensuring colloidal stability; (ii) once diluted in PBS, osmotic swelling-driven forces trigger the enlargement of the polymeric mesh with an ensuing increase of coacervate size and porosity.
Collapse
|
10
|
Lee R, Choi YJ, Jeong MS, Park YI, Motoyama K, Kim MW, Kwon SH, Choi JH. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer. Bioconjug Chem 2020; 31:923-932. [DOI: 10.1021/acs.bioconjchem.0c00048] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Ruda Lee
- International Research Organization for Advanced Science and Technology (IROAST), Kumamoto University, Kumamoto 860-8555, Japan
| | - Yu Jin Choi
- Korea Basic Science Institute, Chuncheon 24341, Republic of Korea
| | | | - Yong Il Park
- School of Chemical Engineering, Chonnam National University, Gwangju 61186, Republic of Korea
| | - Keiichi Motoyama
- Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860-8555, Japan
| | - Min Woo Kim
- International Research Organization for Advanced Science and Technology (IROAST), Kumamoto University, Kumamoto 860-8555, Japan
| | - Seung-Hae Kwon
- Korea Basic Science Institute, Seoul 02841, Republic of Korea
| | - Jung Hoon Choi
- Department of Anatomy & Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University, Chuncheon 24341, Republic of Korea
| |
Collapse
|
11
|
Sabourian P, Ji J, Lotocki V, Moquin A, Hanna R, Frounchi M, Maysinger D, Kakkar A. Facile design of autogenous stimuli-responsive chitosan/hyaluronic acid nanoparticles for efficient small molecules to protein delivery. J Mater Chem B 2020; 8:7275-7287. [DOI: 10.1039/d0tb00772b] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Chitosan is functionalized with oxidative stress-sensitive thioketal entities in a one-pot methodology, and self-assembled into drugs or protein loaded dual stimuli responsive nanoparticles, which kill glioblastoma cells and increase nerve outgrowth.
Collapse
Affiliation(s)
- Parinaz Sabourian
- Department of Chemistry
- McGill University
- Montréal
- Canada
- Department of Chemical and Petroleum Engineering
| | - Jeff Ji
- Department of Pharmacology and Therapeutics
- McGill University
- Montréal
- Canada
| | | | - Alexandre Moquin
- Department of Chemistry
- McGill University
- Montréal
- Canada
- Department of Pharmacology and Therapeutics
| | - Ramez Hanna
- Department of Chemistry
- McGill University
- Montréal
- Canada
| | - Masoud Frounchi
- Department of Chemical and Petroleum Engineering
- Sharif University of Technology
- Tehran
- Iran
| | - Dusica Maysinger
- Department of Pharmacology and Therapeutics
- McGill University
- Montréal
- Canada
| | - Ashok Kakkar
- Department of Chemistry
- McGill University
- Montréal
- Canada
| |
Collapse
|
12
|
Rios de la Rosa JM, Pingrajai P, Pelliccia M, Spadea A, Lallana E, Gennari A, Stratford IJ, Rocchia W, Tirella A, Tirelli N. Binding and Internalization in Receptor-Targeted Carriers: The Complex Role of CD44 in the Uptake of Hyaluronic Acid-Based Nanoparticles (siRNA Delivery). Adv Healthc Mater 2019; 8:e1901182. [PMID: 31738017 DOI: 10.1002/adhm.201901182] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2019] [Revised: 10/16/2019] [Indexed: 12/11/2022]
Abstract
CD44 is an endocytic hyaluronic acid (HA) receptor, and is overexpressed in many carcinomas. This has encouraged the use of HA to design CD44-targeting carriers. This paper is about dissecting the mechanistic role of CD44. Here, HA-decorated nanoparticles are used to deliver siRNA to both tumoral (AsPC-1, PANC-1, HT-29, HCT-116) and non-tumoral (fibroblasts, differently polarized THP-1 macrophages, HUVEC) human cell lines, evaluating the initial binding of the nanoparticles, their internalization rate, and the silencing efficiency (cyclophilin B (PPIB) gene). Tumoral cells internalize faster and experience higher silencing than non-tumoral cells. This is promising as it suggests that, in a tumor, HA nanocarriers may have limited off-target effects. More far-reaching is the inter-relation between the four parameters of the study: CD44 expression, HA binding on cell surfaces, internalization rate, and silencing efficiency. No correlation is found between binding (an early event) and any of the other parameters, whereas silencing correlates both with speed of the internalization process and CD44 expression. This study confirms on one hand that HA-based carriers can perform a targeted action, but on the other it suggests that this may not be due to a selective binding event, but rather to a later recognition leading to selective internalization.
Collapse
Affiliation(s)
- Julio M Rios de la Rosa
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK
| | - Ponpawee Pingrajai
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9PL, UK
| | - Maria Pelliccia
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9PL, UK
| | - Alice Spadea
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9PL, UK
| | - Enrique Lallana
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9PL, UK
| | - Arianna Gennari
- Laboratory for Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, 16163, Genova, Italy
| | - Ian J Stratford
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9PL, UK
| | - Walter Rocchia
- CONCEPT Lab, Fondazione Istituto Italiano di Tecnologia, 16163, Genova, Italy
| | - Annalisa Tirella
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9PL, UK
| | - Nicola Tirelli
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9PL, UK
- Laboratory for Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, 16163, Genova, Italy
| |
Collapse
|
13
|
Quagliariello V, Coppola C, Mita DG, Piscopo G, Iaffaioli RV, Botti G, Maurea N. Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 2019; 69:1-8. [PMID: 30903913 DOI: 10.1016/j.etap.2019.03.006] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 02/12/2019] [Accepted: 03/05/2019] [Indexed: 06/09/2023]
Abstract
Endocrine disrupters are strictly associated to cancer and several cardiovascular risk factors. Bisphenol A (BPA) is an endocrine disrupter commonly used in the manufacturing of plastics based on polycarbonate, polyvinyl chloride and resins. Our study aims to investigate whether BPA may cause pro-oxidative and pro-inflammatory effects on cardiomyoblasts, thus exacerbating the Doxorubicin (DOXO)-induced cardiotoxicity phenomena. We tested the metabolic effects of BPA at low doses analyzing its affections on the intracellular calcium uptake, oxidative stress, lipid peroxidation and production of nitric oxide and interleukins. Co-incubation of BPA and DOXO significantly reduced the cardiomyoblast viability, compared to only DOXO exposure cells. The mechanisms underlying these effects are based on the stimulation of the intracellular calcium accumulation and lipid peroxidation. Notably, BPA increase the production of pro-inflammatory interleukins involved in cardiovascular diseases as well as in DOXO-Induced cardiotoxicity phenomena. This study provides a rationale for translational studies in the field of cardio-oncology.
Collapse
Affiliation(s)
- V Quagliariello
- Division of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione Pascale, Napoli, Italy.
| | - C Coppola
- Division of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione Pascale, Napoli, Italy
| | - D G Mita
- Institute of Genetics and Biophysics of CNR and National Laboratory on Endocrine Disruptors of INBB Naples, Italy
| | - G Piscopo
- Division of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione Pascale, Napoli, Italy
| | - R V Iaffaioli
- Association for Multidisciplinary Studies in Oncology and Mediterranean Diet, Piazza Nicola Amore, Naples, Italy
| | - G Botti
- Scientific Direction, Istituto Nazionale Tumori, IRCCS, Fondazione Pascale, Napoli, Italy
| | - N Maurea
- Division of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione Pascale, Napoli, Italy
| |
Collapse
|
14
|
Spadea A, Rios de la Rosa JM, Tirella A, Ashford MB, Williams KJ, Stratford IJ, Tirelli N, Mehibel M. Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44. Mol Pharm 2019; 16:2481-2493. [PMID: 31013093 DOI: 10.1021/acs.molpharmaceut.9b00083] [Citation(s) in RCA: 63] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The development of delivery systems capable of tumor targeting represents a promising strategy to overcome issues related to nonspecific effects of conventional anticancer therapies. Currently, one of the most investigated agents for cancer targeting is hyaluronic acid (HA), since its receptor, CD44, is overexpressed in many cancers. However, most of the studies on CD44/HA interaction have been so far performed in cell-free or genetically modified systems, thus leaving some uncertainty regarding which cell-related factors influence HA binding and internalization (collectively called "uptake") into CD44-expressing cells. To address this, the expression of CD44 (both standard and variants, designated CD44s and CD44v, respectively) was evaluated in human dermal fibroblasts (HDFs) and a large panel of cancer cell lines, including breast, prostate, head and neck, pancreatic, ovarian, colorectal, thyroid, and endometrial cancers. Results showed that CD44 isoform profiles and expression levels vary across the cancer cell lines and HDF and are not consistent within the cell origin. Using composite information of CD44 expression, HA binding, and internalization, we found that the expression of CD44v can negatively influence the uptake of HA, and, instead, when cells primarily expressed CD44s, a positive correlation was observed between expression and uptake. In other words, CD44shigh cells bound and internalized more HA compared to CD44slow cells. Moreover, CD44shigh HDFs were less efficient in uptaking HA compared to CD44shigh cancer cells. The experiments described here are the first step toward understanding the interplay between CD44 expression, its functionality, and the underlying mechanism(s) for HA uptake. The results show that factors other than the amount of CD44 receptor can play a role in the interaction with HA, and this represents an important advance with respect to the design of HA-based carriers and the selection of tumors to treat according to their CD44 expression profile.
Collapse
Affiliation(s)
- Alice Spadea
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health , University of Manchester and Manchester Academic Health Science Centre , Stopford Building , Manchester M13 9PT , U.K
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , North West Centre of Advanced Drug Delivery (NoWCADD) , Stopford Building , Manchester M13 9PT , U.K
- Manchester Cancer Research Centre , The University of Manchester , 555 Wilmslow Road , Manchester M20 4GJ , U.K
| | - Julio Manuel Rios de la Rosa
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health , University of Manchester and Manchester Academic Health Science Centre , Stopford Building , Manchester M13 9PT , U.K
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , North West Centre of Advanced Drug Delivery (NoWCADD) , Stopford Building , Manchester M13 9PT , U.K
- BiOncoTech Therapeutics S.L., Science 2 Business Foundation , C/ Santiago Grisolia 2 Tres Cantos , Madrid 28760 , Spain
| | - Annalisa Tirella
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health , University of Manchester and Manchester Academic Health Science Centre , Stopford Building , Manchester M13 9PT , U.K
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , North West Centre of Advanced Drug Delivery (NoWCADD) , Stopford Building , Manchester M13 9PT , U.K
| | - Marianne B Ashford
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , North West Centre of Advanced Drug Delivery (NoWCADD) , Stopford Building , Manchester M13 9PT , U.K
- Pharmaceutical Sciences, Innovative Medicines Biotech Unit , AstraZeneca , Macclesfield SK10 2NA , U.K
| | - Kaye J Williams
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health , University of Manchester and Manchester Academic Health Science Centre , Stopford Building , Manchester M13 9PT , U.K
- Manchester Cancer Research Centre , The University of Manchester , 555 Wilmslow Road , Manchester M20 4GJ , U.K
| | - Ian J Stratford
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health , University of Manchester and Manchester Academic Health Science Centre , Stopford Building , Manchester M13 9PT , U.K
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , North West Centre of Advanced Drug Delivery (NoWCADD) , Stopford Building , Manchester M13 9PT , U.K
- Manchester Cancer Research Centre , The University of Manchester , 555 Wilmslow Road , Manchester M20 4GJ , U.K
| | - Nicola Tirelli
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health , University of Manchester and Manchester Academic Health Science Centre , Stopford Building , Manchester M13 9PT , U.K
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , North West Centre of Advanced Drug Delivery (NoWCADD) , Stopford Building , Manchester M13 9PT , U.K
- Laboratory of Polymers and Biomaterials , Fondazione Istituto Italiano di Tecnologia , 16163 Genova , Italy
| | - Manal Mehibel
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health , University of Manchester and Manchester Academic Health Science Centre , Stopford Building , Manchester M13 9PT , U.K
- Department of Radiation Oncology , Stanford University , Stanford , California 94305-5847 , United States
| |
Collapse
|
15
|
Tirella A, Kloc-Muniak K, Good L, Ridden J, Ashford M, Puri S, Tirelli N. CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment. Int J Pharm 2019; 561:114-123. [DOI: 10.1016/j.ijpharm.2019.02.032] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2018] [Revised: 01/21/2019] [Accepted: 02/18/2019] [Indexed: 12/15/2022]
|
16
|
Synergistic clearance of intracellular pathogens by hyaluronan-streptomycin micelles encapsulated with rapamycin. Carbohydr Polym 2019; 210:364-371. [DOI: 10.1016/j.carbpol.2019.01.068] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2018] [Revised: 01/21/2019] [Accepted: 01/21/2019] [Indexed: 02/02/2023]
|
17
|
Furlani F, Sacco P, Decleva E, Menegazzi R, Donati I, Paoletti S, Marsich E. Chitosan Acetylation Degree Influences the Physical Properties of Polysaccharide Nanoparticles: Implication for the Innate Immune Cells Response. ACS APPLIED MATERIALS & INTERFACES 2019; 11:9794-9803. [PMID: 30768897 DOI: 10.1021/acsami.8b21791] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The aim of the present contribution is twofold as it reports (i) on the role played by chitosan acetylation degree for the stability of nanoparticles (NPs) formed with hyaluronan and (ii) on the effect of the interaction of such NPs with immune cells. Chitosans with similar viscosity-average molecular weight, [Formula: see text], (i.e., 200 000) and different fractions of acetylated units ( FA) together with low-molecular-weight hyaluronan were chosen for developing a select library of formulations via electrostatic complex coacervation. The resulting NPs were analyzed in terms of size, polydispersity, surface charge, and stability in physiological-mimicked media by dynamic light scattering. Only medium acetylated chitosan ( FA = 0.16) guaranteed the stability of NPs. To explore the effect of NPs interaction with immune cells, the release of proinflammatory cytokines and the reactive oxygen species production by human macrophages and neutrophils, respectively, were evaluated. Strikingly, a structure-function relationship emerged, showing that NPs made of chitosans with FA = 0.02, 0.25, 0.46, and 0.63 manifested a proinflammatory activity, linked to the instability of the system. Conversely, NPs made of chitosan with FA = 0.16 neither modified the functional response of macrophages nor that of neutrophils. Of note, such NPs were found to possess additional properties potentially advantageous in applications such as delivery of therapeutics to target inflamed sites: (i) they are devoid of cytotoxic effects, (ii) they avoid engulfment during the early stage of interaction with macrophages, and (iii) they are muco-adhesive, thereby providing for site-specificity and long-residence effects.
Collapse
Affiliation(s)
- Franco Furlani
- Department of Life Sciences , University of Trieste , Via L. Giorgieri 5 , I-34127 Trieste , Italy
| | - Pasquale Sacco
- Department of Life Sciences , University of Trieste , Via L. Giorgieri 5 , I-34127 Trieste , Italy
| | - Eva Decleva
- Department of Life Sciences , University of Trieste , Via L. Giorgieri 5 , I-34127 Trieste , Italy
| | - Renzo Menegazzi
- Department of Life Sciences , University of Trieste , Via L. Giorgieri 5 , I-34127 Trieste , Italy
| | - Ivan Donati
- Department of Life Sciences , University of Trieste , Via L. Giorgieri 5 , I-34127 Trieste , Italy
| | - Sergio Paoletti
- Department of Life Sciences , University of Trieste , Via L. Giorgieri 5 , I-34127 Trieste , Italy
| | - Eleonora Marsich
- Department of Medicine, Surgery and Health Sciences , University of Trieste , Piazza dell'Ospitale 1 , I-34129 Trieste , Italy
| |
Collapse
|
18
|
Gennari A, Rios de la Rosa JM, Hohn E, Pelliccia M, Lallana E, Donno R, Tirella A, Tirelli N. The different ways to chitosan/hyaluronic acid nanoparticles: templated vs direct complexation. Influence of particle preparation on morphology, cell uptake and silencing efficiency. BEILSTEIN JOURNAL OF NANOTECHNOLOGY 2019; 10:2594-2608. [PMID: 31976191 PMCID: PMC6964650 DOI: 10.3762/bjnano.10.250] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Accepted: 12/02/2019] [Indexed: 05/02/2023]
Abstract
This study is about linking preparative processes of nanoparticles with the morphology of the nanoparticles and with their efficiency in delivering payloads intracellularly. The nanoparticles are composed of hyaluronic acid (HA) and chitosan; the former can address a nanoparticle to cell surface receptors such as CD44, the second allows both for entrapment of nucleic acids and for an endosomolytic activity that facilitates their liberation in the cytoplasm. Here, we have systematically compared nanoparticles prepared either A) through a two-step process based on intermediate (template) particles produced via ionotropic gelation of chitosan with triphosphate (TPP), which are then incubated with HA, or B) through direct polyelectrolyte complexation of chitosan and HA. Here we demonstrate that HA is capable to quantitatively replace TPP in the template process and significant aggregation takes place during the TPP-HA exchange. The templated chitosan/HA nanoparticles therefore have a mildly larger size (measured by dynamic light scattering alone or by field flow fractionation coupled to static or dynamic light scattering), and above all a higher aspect ratio (R g/R H) and a lower fractal dimension. We then compared the kinetics of uptake and the (antiluciferase) siRNA delivery performance in murine RAW 264.7 macrophages and in human HCT-116 colorectal tumor cells. The preparative method (and therefore the internal particle morphology) had little effect on the uptake kinetics and no statistically relevant influence on silencing (templated particles often showing a lower silencing). Cell-specific factors, on the contrary, overwhelmingly determined the efficacy of the carriers, with, e.g., those containing low-MW chitosan performing better in macrophages and those with high-MW chitosan in HCT-116.
Collapse
Affiliation(s)
- Arianna Gennari
- Laboratory of Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, 16163 Genova, Italy
| | - Julio M Rios de la Rosa
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, United Kingdom
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, Stopford Building, University of Manchester and Manchester Academic Health Science Centre, Manchester, M13 9PT, United Kingdom
- current address: Cambridge Enterprise Limited, University of Cambridge, Hauser Forum, 3 Charles Babbage Rd, Cambridge, CB3 0GT, United Kingdom
| | - Erwin Hohn
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, Stopford Building, University of Manchester and Manchester Academic Health Science Centre, Manchester, M13 9PT, United Kingdom
- current address: Novartis EBEWE Pharma Ges.m.b.H. Nfg.KG, Lehenau 10a, 5325 Plainfield, Austria
| | - Maria Pelliccia
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, United Kingdom
- current address: Orchard Therapeutics plc., 108 Cannon Street, EC4N 6EU London, United Kingdom
| | - Enrique Lallana
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, United Kingdom
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, Stopford Building, University of Manchester and Manchester Academic Health Science Centre, Manchester, M13 9PT, United Kingdom
| | - Roberto Donno
- Laboratory of Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, 16163 Genova, Italy
| | - Annalisa Tirella
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, United Kingdom
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, Stopford Building, University of Manchester and Manchester Academic Health Science Centre, Manchester, M13 9PT, United Kingdom
| | - Nicola Tirelli
- Laboratory of Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, 16163 Genova, Italy
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, United Kingdom
| |
Collapse
|
19
|
Chiesa E, Dorati R, Pisani S, Conti B, Bergamini G, Modena T, Genta I. The Microfluidic Technique and the Manufacturing of Polysaccharide Nanoparticles. Pharmaceutics 2018; 10:pharmaceutics10040267. [PMID: 30544868 PMCID: PMC6321127 DOI: 10.3390/pharmaceutics10040267] [Citation(s) in RCA: 56] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2018] [Revised: 11/16/2018] [Accepted: 11/27/2018] [Indexed: 12/22/2022] Open
Abstract
The microfluidic technique has emerged as a promising tool to accelerate the clinical translation of nanoparticles, and its application affects several aspects, such as the production of nanoparticles and the in vitro characterization in the microenvironment, mimicking in vivo conditions. This review covers the general aspects of the microfluidic technique and its application in several fields, such as the synthesis, recovering, and samples analysis of nanoparticles, and in vitro characterization and their in vivo application. Among these, advantages in the production of polymeric nanoparticles in a well-controlled, reproducible, and high-throughput manner have been highlighted, and detailed descriptions of microfluidic devices broadly used for the synthesis of polysaccharide nanoparticles have been provided. These nanoparticulate systems have drawn attention as drug delivery vehicles over many years; nevertheless, their synthesis using the microfluidic technique is still largely unexplored. This review deals with the use of the microfluidic technique for the synthesis of polysaccharide nanoparticles; evaluating features of the most studied polysaccharide drug carriers, such as chitosan, hyaluronic acid, and alginate polymers. The critical assessment of the most recent research published in literature allows us to assume that microfluidics will play an important role in the discovery and clinical translation of nanoplatforms.
Collapse
Affiliation(s)
- Enrica Chiesa
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
| | - Rossella Dorati
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
| | - Silvia Pisani
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
| | - Bice Conti
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
| | - Gloria Bergamini
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
| | - Tiziana Modena
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
| | - Ida Genta
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
| |
Collapse
|
20
|
Mukwaya V, Wang C, Dou H. Saccharide-based nanocarriers for targeted therapeutic and diagnostic applications. POLYM INT 2018. [DOI: 10.1002/pi.5702] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Vincent Mukwaya
- State Key Laboratory of Metal Matrix Composites, School of Materials Science and Engineering; Shanghai Jiao Tong University; Shanghai PR China
| | - Chenglong Wang
- State Key Laboratory of Metal Matrix Composites, School of Materials Science and Engineering; Shanghai Jiao Tong University; Shanghai PR China
| | - Hongjing Dou
- State Key Laboratory of Metal Matrix Composites, School of Materials Science and Engineering; Shanghai Jiao Tong University; Shanghai PR China
| |
Collapse
|
21
|
Yang Y, Zhu H, Wang J, Fang Q, Peng Z. Enzymatically Disulfide-Crosslinked Chitosan/Hyaluronic Acid Layer-by-Layer Self-Assembled Microcapsules for Redox-Responsive Controlled Release of Protein. ACS APPLIED MATERIALS & INTERFACES 2018; 10:33493-33506. [PMID: 30203959 DOI: 10.1021/acsami.8b07120] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Disulfide-crosslinked hollow polyelectrolyte microcapsules composed of thiolated chitosan (CS-SH) and hyaluronic acid (HA-SH) were prepared by combining the layer-by-layer (LBL) technique and horseradish peroxidase (HRP)-mediated oxidative cross-linking reaction in mild conditions. FITC-dextran-doped CaCO3 microspheres were used as template core and removed after LBL depositing CS-SH and HA-SH on the surface. The disulfide-crosslinked (CS/HA) microcapsules were readily fabricated by HRP-mediated oxidative coupling of the thiol groups in CS/HA shell layer in the presence of HRP (10 units/mL) and Tyramine hydrochloride (Tyr, 35 mmol/L). The kinetics of enzymatic disulfide-crosslinking reaction was investigated through the real-time monitoring of the consumption of thiol groups by UV absorption spectra. It found that the formation of disulfide linkages by the enzymatic thiol oxidation reaction showed a gradual acceleration. The disulfide-crosslinked CS/HA hydrogel were rapidly formed in gelation time between approximately 17 and 30 min, which were dependent on the concentrations of HRP and Tyr. The disulfide linkages endowed the microcapsule-enhanced physical stability and low permeability under physiological conditions and redox-responsive degradability in reducing environments. The structural stability of disulfide-crosslinked (CS/HA) microcapsules was visualized by confocal laser scanning microscopy in phosphate-buffered saline containing 5.0 mmol/L dithiothreitol (DTT) to evaluate the redox-responsive disassembly process. Redox-responsive controlled release of encapsulated FITC-dextran from the disulfide-crosslinked (CS/HA) microcapsules were obtained. The release profiles of FITC-dextran could be manipulated by controlling the shell thickness and the concentration of DTT. The conformational stability analyses and more than 94% esterase activity of released bovine serum albumin (BSA) from (CS/HA) microcapsules conformed that the structural integrity and bioactivity were well preserved during the encapsulation and release process. The microcapsules exhibited excellent cytocompatibility for HEK 293 cells up to a concentration of 1.0 mg/mL. The microcapsules efficiently delivered loaded FITC-BSA into HeLa cells and released the protein in the reducing cytosol. This study proposed a novel approach for producing disulfide-crosslinked microcarriers for intracellular delivery and redox-responsive controlled release of protein.
Collapse
Affiliation(s)
- Yue Yang
- School of Materials Science and Engineering , Nanchang University , Nanchang 330031 , China
| | - Hekang Zhu
- School of Materials Science and Engineering , Nanchang University , Nanchang 330031 , China
| | - Ji Wang
- School of Materials Science and Engineering , Nanchang University , Nanchang 330031 , China
| | - Qian Fang
- School of Materials Science and Engineering , Nanchang University , Nanchang 330031 , China
| | - Zhiping Peng
- School of Materials Science and Engineering , Nanchang University , Nanchang 330031 , China
| |
Collapse
|
22
|
Deng RH, Qiu B, Zhou PH. Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta. JOURNAL OF MATERIALS SCIENCE. MATERIALS IN MEDICINE 2018; 29:155. [PMID: 30276528 PMCID: PMC6182723 DOI: 10.1007/s10856-018-6160-3] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/02/2018] [Accepted: 09/18/2018] [Indexed: 05/16/2023]
Abstract
Synovial inflammation mainly resulting from interleukin-1 beta (IL-1β) plays a crucial role in the early and late stage of osteoarthritis. Recent progress in therapeutic gene delivery systems has led to promising strategies for local sustained target gene expression. The aim of this study was to design a nanoparticle made of chitosan (CS)/hyaluronic acid (HA)/plasmid-DNA (pDNA) encoding IL-1 receptor antagonist gene (pIL-1Ra) and furtherly use it to transfect the primary synoviocytes, and then investigate whether CS/HA/pIL-1Ra nanoparticles could make the synoviocytes overexpress functional IL-1Ra to attenuate inflammation induced by IL-1β. In this study, CS was modified with HA to generate CS/HA nanoparticles and then combined with pIL-1Ra to form CS/HA/pIL-1Ra nanoparticles. The physicochemical characteristics results showed that CS/HA nanoparticles exhibited an appropriate particle size (144.9 ± 2.8 nm) and positive zeta potential ( + 28 mV). The gel retardation assay revealed that pDNA was effectively protected and released in a sustained manner more than 15 days. Cytotoxicity results showed that CS/HA/pIL-1Ra nanoparticles had a safe range (0-80 μg/ml) for the application to synoviocytes. RT-qPCR and western blot analysis demonstrated that CS/HA/pIL-1Ra nanoparticles were able to increase IL-1Ra expression in primary synoviocytes, and reduce the mRNA and protein levels of matrix metalloproteinase-3 (MMP-3), matrix metalloproteinase-13 (MMP-13), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in IL-1β-induced synoviocytes. Our findings indicated that CS/HA/pIL-1Ra nanoparticles efficiently transfected synoviocytes and attenuated synovitis induced by IL-1β, which will provide a potential strategy for OA synovitis.
Collapse
Affiliation(s)
- Rong-Hui Deng
- Department of Orthopedics, Renmin Hospital of Wuhan University, Ziyang Road 99, Wuhan, 430060, China
| | - Bo Qiu
- Department of Orthopedics, Renmin Hospital of Wuhan University, Ziyang Road 99, Wuhan, 430060, China
| | - Pang-Hu Zhou
- Department of Orthopedics, Renmin Hospital of Wuhan University, Ziyang Road 99, Wuhan, 430060, China.
| |
Collapse
|
23
|
Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity. Nutrients 2018; 10:nu10091304. [PMID: 30223482 PMCID: PMC6164259 DOI: 10.3390/nu10091304] [Citation(s) in RCA: 58] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2018] [Revised: 09/11/2018] [Accepted: 09/12/2018] [Indexed: 02/07/2023] Open
Abstract
Doxorubicin is a highly active antineoplastic agent, but its clinical use is limited because of its cardiotoxicity. Although nutraceuticals endowed with anti-inflammatory properties exert cardioprotective activity, their bioavailability and stability are inconsistent. In an attempt to address this issue, we evaluated whether bioavailable nanoemulsions loaded with nutraceuticals (curcumin and fresh and dry tomato extracts rich in lycopene) protect cardiomyoblasts (H9C2 cells) from doxorubicin-induced toxicity. Nanoemulsions were produced with a high-pressure homogenizer. H9C2 cells were incubated with nanoemulsions loaded with different nutraceuticals alone or in combination with doxorubicin. Cell viability was evaluated with a modified MTT method. The levels of the lipid peroxidation products malondialdehyde (MDA) and 4-hydroxy-2-butanone (4-HNA), and of the cardiotoxic-related interleukins IL-6, IL-8, IL-1β and IL-10, tumor necrosis factor-alpha (TNF-α), and nitric oxide were analyzed in cardiomyoblasts. The hydrodynamic size of nanoemulsions was around 100 nm. Cell viability enhancement was 35–40% higher in cardiomyoblasts treated with nanoemulsion + doxorubicin than in cardiomyoblasts treated with doxorubicin alone. Nanoemulsions also protected against oxidative stress as witnessed by a reduction of MDA and 4-HNA. Notably, nanoemulsions inhibited the release of IL-6, IL-8, IL-1β, TNF-α and nitric oxide by around 35–40% and increased IL-10 production by 25–27% versus cells not treated with emulsions. Of the nutraceuticals evaluated, lycopene-rich nanoemulsions had the best cardioprotective profile. In conclusion, nanoemulsions loaded with the nutraceuticals described herein protect against cardiotoxicity, by reducing inflammation and lipid oxidative stress. These results set the stage for studies in preclinical models.
Collapse
|
24
|
Almalik A, Alradwan I, Majrashi MA, Alsaffar BA, Algarni AT, Alsuabeyl MS, Alrabiah H, Tirelli N, Alhasan AH. Cellular responses of hyaluronic acid-coated chitosan nanoparticles. Toxicol Res (Camb) 2018; 7:942-950. [PMID: 30310671 PMCID: PMC6116812 DOI: 10.1039/c8tx00041g] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2018] [Accepted: 05/22/2018] [Indexed: 12/22/2022] Open
Abstract
In recent years, nanotechnology has been proven to offer promising biomedical applications for in vivo diagnostics and drug delivery, stressing the importance of thoroughly investigating the biocompatibility of potentially translatable nanoparticles (NPs). Herein, we report the cellular responses of uncoated chitosan NPs (CS NPs) and hyaluronic acid-coated chitosan NPs (HA-CS NPs) when introduced into Chinese hamster ovary cells (CHO-K1) in a dose-dependent manner (2.5, 0.25, 0.025, 0.0025, and 0.00025 mg mL-1) at two time points (24 and 48 h). MTS assay, cell proliferation, showed a decrease in the viability of cells when treated with 0.25 and 2.5 mg mL-1 CS NPs. When exposed to high doses of CS NPs, the lactate dehydrogenase (LDH) enzyme started to leak out of the cells and the cellular levels of mitochondrial potentials were significantly reduced accompanied by a high production of intracellular reactive oxygen species (ROS). Our study provides molecular evidence of the biocompatibility offered by HA-CS NPs, through ROS scavenging capabilities rescuing cells from the oxidative stress, showing no observed cellular stress and thereby revealing the promising effect of anionic hyaluronic acid to significantly reduce the cytotoxicity of CS NPs. Our findings are important to accelerate the translation and utilization of HA-CS NPs in drug delivery, demonstrating the pronounced effect of surface modifications on modulating the biological responses.
Collapse
Affiliation(s)
- Abdulaziz Almalik
- National Center for Pharmaceuticals , Life science and Environment Research Institute , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia .
- KACST-BWH/Harvard Center of Excellence for Biomedicine , Joint Centers of Excellence Program , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia
| | - Ibrahim Alradwan
- National Center for Pharmaceuticals , Life science and Environment Research Institute , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia .
| | - Majed A Majrashi
- National Center for Pharmaceuticals , Life science and Environment Research Institute , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia .
- KACST-BWH/Harvard Center of Excellence for Biomedicine , Joint Centers of Excellence Program , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia
| | - Bashayer A Alsaffar
- National Center for Pharmaceuticals , Life science and Environment Research Institute , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia .
| | - Abdulmalek T Algarni
- National Center for Pharmaceuticals , Life science and Environment Research Institute , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia .
| | - Mohammed S Alsuabeyl
- National Center for Pharmaceuticals , Life science and Environment Research Institute , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia .
| | - Haitham Alrabiah
- Department of Pharmaceutical Chemistry , College of Pharmacy , King Saud University , P.O. Box 2457 , Riyadh , 11451 , Saudi Arabia
| | - Nicola Tirelli
- NorthWest Centre for Advanced Drug Delivery (NoWCADD) , Division of Pharmacy and Optometry , School of Health Sciences , University of Manchester , Manchester , UK
| | - Ali H Alhasan
- National Center for Pharmaceuticals , Life science and Environment Research Institute , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia .
- KACST-BWH/Harvard Center of Excellence for Biomedicine , Joint Centers of Excellence Program , King Abdulaziz City for Science and Technology (KACST) , P.O. Box 6086 , Riyadh 11461 , Saudi Arabia
| |
Collapse
|
25
|
Sacco P, Furlani F, De Marzo G, Marsich E, Paoletti S, Donati I. Concepts for Developing Physical Gels of Chitosan and of Chitosan Derivatives. Gels 2018; 4:E67. [PMID: 30674843 PMCID: PMC6209275 DOI: 10.3390/gels4030067] [Citation(s) in RCA: 66] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2018] [Accepted: 08/07/2018] [Indexed: 02/06/2023] Open
Abstract
Chitosan macro- and micro/nano-gels have gained increasing attention in recent years, especially in the biomedical field, given the well-documented low toxicity, degradability, and non-immunogenicity of this unique biopolymer. In this review we aim at recapitulating the recent gelling concepts for developing chitosan-based physical gels. Specifically, we describe how nowadays it is relatively simple to prepare networks endowed with different sizes and shapes simply by exploiting physical interactions, namely (i) hydrophobic effects and hydrogen bonds-mostly governed by chitosan chemical composition-and (ii) electrostatic interactions, mainly ensured by physical/chemical chitosan features, such as the degree of acetylation and molecular weight, and external parameters, such as pH and ionic strength. Particular emphasis is dedicated to potential applications of this set of materials, especially in tissue engineering and drug delivery sectors. Lastly, we report on chitosan derivatives and their ability to form gels. Additionally, we discuss the recent findings on a lactose-modified chitosan named Chitlac, which has proved to form attractive gels both at the macro- and at the nano-scale.
Collapse
Affiliation(s)
- Pasquale Sacco
- Department of Life Sciences, University of Trieste, Via Licio Giorgieri 5, I-34127 Trieste, Italy.
| | - Franco Furlani
- Department of Life Sciences, University of Trieste, Via Licio Giorgieri 5, I-34127 Trieste, Italy.
| | - Gaia De Marzo
- Department of Life Sciences, University of Trieste, Via Licio Giorgieri 5, I-34127 Trieste, Italy.
| | - Eleonora Marsich
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazza dell'Ospitale 1, I-34125 Trieste, Italy.
| | - Sergio Paoletti
- Department of Life Sciences, University of Trieste, Via Licio Giorgieri 5, I-34127 Trieste, Italy.
| | - Ivan Donati
- Department of Life Sciences, University of Trieste, Via Licio Giorgieri 5, I-34127 Trieste, Italy.
| |
Collapse
|
26
|
Barbarisi M, Iaffaioli RV, Armenia E, Schiavo L, De Sena G, Tafuto S, Barbarisi A, Quagliariello V. Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme. J Cell Physiol 2018; 233:6550-6564. [PMID: 29030990 DOI: 10.1002/jcp.26238] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2017] [Accepted: 10/12/2017] [Indexed: 12/12/2022]
Abstract
Glioblastoma multiforme is the most common and aggressive primary brain cancer with only ∼3% of patients surviving more than 3 years from diagnosis. Several mechanisms are involved in drug and radiation resistance to anticancer treatments and among them one of the most important factors is the tumor microenvironment status, characterized by cancer cell hypersecretion of interleukins and cytokines. The aim of our research was the synthesis of a nanocarrier of quercetin combined with temozolomide, to enhance the specificity and efficacy of this anticancer drug commonly used in glioblastoma treatment. The nanohydrogel increased the internalization and cytotoxicity of quercetin in human glioblastoma cells and, when co-delivered with temozolomide, contribute to an improved anticancer effect. The nanohydrogel loaded with quercetin had the ability to recognize CD44 receptor, a brain cancer cell marker, through an energy and caveolae dependent mechanism of internalization. Moreover, nanohydrogel of quercetin was able to reduce significantly IL-8, IL-6, and VEGF production in pro-inflammatory conditions with interesting implications on the mechanism of glioblastoma cells drug resistance. In summary, novel CD44 targeted polymeric based nanocarriers appear to be proficient in mediating site-specific delivery of quercetin via CD44 receptor in glioblastoma cells. This targeted therapy lead to an improved therapeutic efficacy of temozolomide by modulating the brain tumor microenvironment.
Collapse
Affiliation(s)
- Manlio Barbarisi
- Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| | - Rosario V Iaffaioli
- Department of Abdominal Oncology, National Cancer Institute, IRCCS - Foundation G. Pascale, Naples, Italy
| | - Emilia Armenia
- Department of Thoracic and Cardio-Respiratory Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| | - Luigi Schiavo
- Department of Thoracic and Cardio-Respiratory Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| | - Gabriele De Sena
- Department of Thoracic and Cardio-Respiratory Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| | - Salvatore Tafuto
- Department of Abdominal Oncology, National Cancer Institute, IRCCS - Foundation G. Pascale, Naples, Italy
| | - Alfonso Barbarisi
- Department of Thoracic and Cardio-Respiratory Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| | - Vincenzo Quagliariello
- Department of Abdominal Oncology, National Cancer Institute, IRCCS - Foundation G. Pascale, Naples, Italy.,Department of Thoracic and Cardio-Respiratory Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| |
Collapse
|
27
|
Montanari E, Di Meo C, Oates A, Coviello T, Matricardi P. Pursuing Intracellular Pathogens with Hyaluronan. From a 'Pro-Infection' Polymer to a Biomaterial for 'Trojan Horse' Systems. Molecules 2018; 23:E939. [PMID: 29670009 PMCID: PMC6017551 DOI: 10.3390/molecules23040939] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2018] [Revised: 04/12/2018] [Accepted: 04/13/2018] [Indexed: 12/12/2022] Open
Abstract
Hyaluronan (HA) is among the most important bioactive polymers in mammals, playing a key role in a number of biological functions. In the last decades, it has been increasingly studied as a biomaterial for drug delivery systems, thanks to its physico-chemical features and ability to target and enter certain cells. The most important receptor of HA is ‘Cluster of Differentiation 44’ (CD44), a cell surface glycoprotein over-expressed by a number of cancers and heavily involved in HA endocytosis. Moreover, CD44 is highly expressed by keratinocytes, activated macrophages and fibroblasts, all of which can act as ‘reservoirs’ for intracellular pathogens. Interestingly, both CD44 and HA appear to play a key role for the invasion and persistence of such microorganisms within the cells. As such, HA is increasingly recognised as a potential target for nano-carriers development, to pursuit and target intracellular pathogens, acting as a ‘Trojan Horse’. This review describes the biological relationship between HA, CD44 and the entry and survival of a number of pathogens within the cells and the subsequent development of HA-based nano-carriers for enhancing the intracellular activity of antimicrobials.
Collapse
Affiliation(s)
- Elita Montanari
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
| | - Chiara Di Meo
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
| | - Angela Oates
- School of Healthcare, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.
| | - Tommasina Coviello
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
| | - Pietro Matricardi
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
| |
Collapse
|
28
|
Rios de la Rosa JM, Tirella A, Tirelli N. Receptor-Targeted Drug Delivery and the (Many) Problems We Know of: The Case of CD44 and Hyaluronic Acid. ACTA ACUST UNITED AC 2018. [DOI: 10.1002/adbi.201800049] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Julio M. Rios de la Rosa
- NorthWest Centre for Advanced Drug Delivery (NoWCADD); School of Health Sciences; University of Manchester; Oxford Road Manchester M13 9PT UK
| | - Annalisa Tirella
- NorthWest Centre for Advanced Drug Delivery (NoWCADD); School of Health Sciences; University of Manchester; Oxford Road Manchester M13 9PT UK
| | - Nicola Tirelli
- NorthWest Centre for Advanced Drug Delivery (NoWCADD); School of Health Sciences; University of Manchester; Oxford Road Manchester M13 9PT UK
- Laboratory of Polymers and Biomaterials; Fondazione Istituto Italiano di Tecnologia; Genova 16163 Italy
| |
Collapse
|
29
|
Fernandez-Piñeiro I, Pensado A, Badiola I, Sanchez A. Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems. Eur J Pharm Biopharm 2018; 125:85-94. [PMID: 29355685 DOI: 10.1016/j.ejpb.2018.01.009] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2017] [Revised: 01/03/2018] [Accepted: 01/13/2018] [Indexed: 01/02/2023]
Abstract
Glycosaminoglycans (GAGs) are natural polymers that are broadly used in gene delivery systems to increase stability as well as decrease toxicity and nonspecific interactions, thereby increasing transfection efficiency. In this work, we propose sorbitan ester-based lipid nanoparticles (SENS) functionalised with the GAGs chondroitin sulfate (CS) and hyaluronic acid (HA) as gene delivery systems. For this purpose, we describe the design and evaluation of these nanosystems loaded with plasmid DNA, including an evaluation of their physicochemical characteristics, stability properties, ability to protect and efficiently transfect cells with Enhanced Green Fluorescent Protein plasmid (pEGFP) in vitro, and biocompatibility both in vitro and in vivo. We confirm that molecules with high biological value and targeting potential, such as HA and CS, can be successfully incorporated into our recently developed sorbitan ester-based nanoparticles (SENS) and that this incorporation leads to effective stabilisation of both nanosystems as well as protects plasmid DNA. We demonstrated that the aforementioned incorporation of HA and CS enables long-term stability of the nanosystems in both liquid and lyophilised states, which is a remarkable property that can aid in their transfer to industry. The ability of these functionalised nanosystems to transfect the A549 cell line without compromising cell viability was also shown, as well as their innocuous safety profile in vivo. Thus, we provide valuable evidence of the suitable properties and potential of these hybrid nanoparticles as gene delivery systems.
Collapse
Affiliation(s)
- I Fernandez-Piñeiro
- Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), Campus Vida, 15782 Santiago de Compostela, Spain
| | - A Pensado
- Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), Campus Vida, 15782 Santiago de Compostela, Spain
| | - I Badiola
- Department of Cell Biology and Histology, Faculty of Medicine and Odontology, University of Basque Country, B° Sarriena, s/n, 48940 Leioa, Spain
| | - A Sanchez
- Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), Campus Vida, 15782 Santiago de Compostela, Spain; Genetics and Biology of the Development of Kidney Diseases Unit, Sanitary Research Institute (IDIS) of the University Hospital Complex of Santiago de Compostela (CHUS), Travesía da Choupana, s/n, 15706 Santiago de Compostela, Spain.
| |
Collapse
|
30
|
Tinoco LMDS, Silva FLOD, Ferreira LAM, Leite EA, Carneiro G. Hyaluronic acid-coated nanoemulsions loaded with a hydrophobic ion pair of all-trans retinoic acid for improving the anticancer activity. BRAZ J PHARM SCI 2018. [DOI: 10.1590/s2175-97902018000417361] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Affiliation(s)
| | | | | | | | - Guilherme Carneiro
- Federal University of Jequitinhonha and Mucuri Valleys, Universidade Federal do Jequitinhonha
| |
Collapse
|
31
|
Targeted Delivery of siRNA Therapeutics to Malignant Tumors. JOURNAL OF DRUG DELIVERY 2017; 2017:6971297. [PMID: 29218233 PMCID: PMC5700508 DOI: 10.1155/2017/6971297] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/31/2017] [Accepted: 10/10/2017] [Indexed: 01/11/2023]
Abstract
Over the past 20 years, a diverse group of ligands targeting surface biomarkers or receptors has been identified with several investigated to target siRNA to tumors. Many approaches to developing tumor-homing peptides, RNA and DNA aptamers, and single-chain variable fragment antibodies by using phage display, in vitro evolution, and recombinant antibody methods could not have been imagined by researchers in the 1980s. Despite these many scientific advances, there is no reason to expect that the ligand field will not continue to evolve. From development of ligands based on novel or existing biomarkers to linking ligands to drugs and gene and antisense delivery systems, several fields have coalesced to facilitate ligand-directed siRNA therapeutics. In this review, we discuss the major categories of ligand-targeted siRNA therapeutics for tumors, as well as the different strategies to identify new ligands.
Collapse
|
32
|
Lallana E, Rios de la Rosa JM, Tirella A, Pelliccia M, Gennari A, Stratford IJ, Puri S, Ashford M, Tirelli N. Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery. Mol Pharm 2017; 14:2422-2436. [PMID: 28597662 DOI: 10.1021/acs.molpharmaceut.7b00320] [Citation(s) in RCA: 98] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Chitosan/hyaluronic acid (HA) nanoparticles can be used to deliver an RNA/DNA cargo to cells overexpressing HA receptors such as CD44. For these systems, unequivocal links have not been established yet between chitosan macromolecular (molecular weight; degree of deacetylation, i.e., charge density) and nanoparticle variables (complexation strength, i.e., stability; nucleic acid protection; internalization rate) on one hand, and transfection efficiency on the other hand. Here, we have focused on the role of avidity on transfection efficiency in the CD44-expressing HCT-116 as a cellular model; we have employed two differently sized payloads (a large luciferase-encoding mRNA and a much smaller anti-Luc siRNA), and a small library of chitosans (variable molecular weight and degree of deactylation). The RNA avidity for chitosan showed-as expected-an inverse relationship: higher avidity-higher polyplex stability-lower transfection efficiency. The avidity of chitosan for RNA appears to lead to opposite effects: higher avidity-higher polyplex stability but also higher transfection efficiency. Surprisingly, the best transfecting particles were those with the lowest propensity for RNA release, although this might be a misleading relationship: for example, the same macromolecular parameters that increase avidity can also boost chitosan's endosomolytic activity, with a strong enhancement in transfection. The performance of these nonviral vectors appears therefore difficult to predict simply on the basis of carrier- or payload-related variables, and a more holistic consideration of the journey of the nanoparticle, from cell uptake to cytosolic bioavailability of payload, is needed. It is also noteworthy that the nanoparticles used in this study showed optimal performance under slightly acidic conditions (pH 6.4), which is promising for applications in a tumoral extracellular environment. It is also worth pointing out that under these conditions we have for the first time successfully delivered mRNA with chitosan/HA nanoparticles.
Collapse
Affiliation(s)
- Enrique Lallana
- NorthWest Centre of Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester , Oxford Road, Manchester, M13 9PT, United Kingdom
| | - Julio M Rios de la Rosa
- NorthWest Centre of Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester , Oxford Road, Manchester, M13 9PT, United Kingdom
| | - Annalisa Tirella
- NorthWest Centre of Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester , Oxford Road, Manchester, M13 9PT, United Kingdom
| | - Maria Pelliccia
- NorthWest Centre of Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester , Oxford Road, Manchester, M13 9PT, United Kingdom
| | - Arianna Gennari
- NorthWest Centre of Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester , Oxford Road, Manchester, M13 9PT, United Kingdom
| | - Ian J Stratford
- NorthWest Centre of Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester , Oxford Road, Manchester, M13 9PT, United Kingdom
| | - Sanyogitta Puri
- Innovative Medicines-Pharmaceutical Sciences, AstraZeneca , Silk Road Business Park, Macclesfield, SK10 2NA, United Kingdom
| | - Marianne Ashford
- Innovative Medicines-Pharmaceutical Sciences, AstraZeneca , Silk Road Business Park, Macclesfield, SK10 2NA, United Kingdom
| | - Nicola Tirelli
- NorthWest Centre of Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester , Oxford Road, Manchester, M13 9PT, United Kingdom
| |
Collapse
|
33
|
Quagliariello V, Iaffaioli RV, Armenia E, Clemente O, Barbarisi M, Nasti G, Berretta M, Ottaiano A, Barbarisi A. Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer. J Cell Physiol 2017; 232:2063-2074. [PMID: 27607841 DOI: 10.1002/jcp.25587] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2016] [Accepted: 09/07/2016] [Indexed: 12/12/2022]
Abstract
The aim of this study is based on the evaluation of anticancer, anti-inflammatory activities, and cellular uptake of hyaluronic acid nanohydrogel of quercetin tested alone and in combination to a macrolide derivative of rapamycin RAD001 (everolimus) on hormone-responsive breast cancer cell line MCF-7. Biological investigations were focused on the receptor mediated cellular internalization of the nanohydrogel and its abilities to reduce secretion of several cytokines (IL-8, IL-6, IL-19), VEGF, and metalloproteases (MMP-2, MMP-9) under pro-inflammatory conditions. Nanohydrogel show a CD44 dependent endocytosis with evident time dependent cytoplasmatic accumulation with abilities to reduce secretion of all cytokines of ∼60% compared to untreated cells. Combination of formulated quercetin and everolimus leads to a synergistic cytotoxic effects with a Combination Index of 0.38. These results highlights the importance of synergistic effect of the hyaluronic acid nanohydrogel of quercetin with everolimus in the regulation of human breast cancer cell proliferation and emphasize the antitumor and anti-inflammatory properties of the nanocarrier. J. Cell. Physiol. 232: 2063-2074, 2017. © 2016 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Vincenzo Quagliariello
- Department of Abdominal Oncology, National Cancer Institute, IRCCS-Foundation G. Pascale, Naples, Italy.,Department of Anaesthesiological, Surgical and Emergency Sciences, Second University of Naples, Naples, Italy.,ASMO (Association for Multidisciplinary Studies in Oncology) and Mediterranean Diet, Naples, Italy
| | - Rosario Vincenzo Iaffaioli
- Department of Abdominal Oncology, National Cancer Institute, IRCCS-Foundation G. Pascale, Naples, Italy.,ASMO (Association for Multidisciplinary Studies in Oncology) and Mediterranean Diet, Naples, Italy
| | - Emilia Armenia
- Department of Anaesthesiological, Surgical and Emergency Sciences, Second University of Naples, Naples, Italy
| | - Ottavia Clemente
- Department of Anaesthesiological, Surgical and Emergency Sciences, Second University of Naples, Naples, Italy
| | - Manlio Barbarisi
- Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy
| | - Guglielmo Nasti
- Department of Abdominal Oncology, National Cancer Institute, IRCCS-Foundation G. Pascale, Naples, Italy
| | | | - Alessandro Ottaiano
- Department of Abdominal Oncology, National Cancer Institute, IRCCS-Foundation G. Pascale, Naples, Italy
| | - Alfonso Barbarisi
- Department of Anaesthesiological, Surgical and Emergency Sciences, Second University of Naples, Naples, Italy
| |
Collapse
|
34
|
Rios de la Rosa JM, Tirella A, Gennari A, Stratford IJ, Tirelli N. The CD44-Mediated Uptake of Hyaluronic Acid-Based Carriers in Macrophages. Adv Healthc Mater 2017; 6. [PMID: 27990775 DOI: 10.1002/adhm.201601012] [Citation(s) in RCA: 77] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Revised: 10/05/2016] [Indexed: 11/07/2022]
Abstract
CD44 is a potentially rewarding target in cancer therapy, although its mechanisms of ligand binding and internalization are still poorly understood. In this study, we have established quantitative relationships between CD44 expression in differently polarized macrophages (M0, M1, and M2-polarized THP-1 human macrophages) and the uptake of hyaluronic acid (HA)-based materials, which are potentially usable for CD44 targeting. We have validated a robust method for macrophage polarization, which sequentially uses differentiating and polarizing factors, and allows to show that CD44 expression depends on polarization (M1 > M0 ≥ M2). It is noteworthy that THP-1 M2 expressed CD44v6, suggesting their suitability as a model of tumor-associated macrophages. In the uptake of HA, both as a soluble polymer and in the form of (siRNA-loaded) nanoparticles, CD44 expression correlated positively with binding, but negatively with internalization. Counterintuitively, it appears that a higher presence of CD44 (in M1) allows a more efficient capture of HA materials, but a lower expression (in M2) is conducive to better internalization. Although possibly cell-specific, this unexpected relationship indicates that the common paradigm "higher CD44 expression = better targetability" is too simplistic; mechanistic details of both receptor presentation and association still need to be elucidated for a predictable targeting behavior.
Collapse
Affiliation(s)
- Julio M Rios de la Rosa
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, M13 9PT, UK
| | - Annalisa Tirella
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, M13 9PT, UK
| | - Arianna Gennari
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, M13 9PT, UK
| | - Ian J Stratford
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, M13 9PT, UK
| | - Nicola Tirelli
- NorthWest Centre for Advanced Drug Delivery (NoWCADD), Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, M13 9PT, UK
| |
Collapse
|
35
|
Raja G, Kim S, Yoon D, Yoon C, Kim S. 1H-NMR-based Metabolomics Studies of the Toxicity of Mesoporous Carbon Nanoparticles in Zebrafish (Danio rerio). B KOREAN CHEM SOC 2017. [DOI: 10.1002/bkcs.11080] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Affiliation(s)
- Ganesan Raja
- Department of Chemistry, Center for Proteome Biophysics and Chemistry Institute for Functional Materials; Pusan National University; Busan 46241 Republic of Korea
| | - Siwon Kim
- Department of Chemistry, Center for Proteome Biophysics and Chemistry Institute for Functional Materials; Pusan National University; Busan 46241 Republic of Korea
| | - Dahye Yoon
- Department of Chemistry, Center for Proteome Biophysics and Chemistry Institute for Functional Materials; Pusan National University; Busan 46241 Republic of Korea
| | - Changshin Yoon
- Department of Chemistry, Center for Proteome Biophysics and Chemistry Institute for Functional Materials; Pusan National University; Busan 46241 Republic of Korea
| | - Suhkmann Kim
- Department of Chemistry, Center for Proteome Biophysics and Chemistry Institute for Functional Materials; Pusan National University; Busan 46241 Republic of Korea
| |
Collapse
|
36
|
Almalik A, Alradwan I, Kalam MA, Alshamsan A. Effect of cryoprotection on particle size stability and preservation of chitosan nanoparticles with and without hyaluronate or alginate coating. Saudi Pharm J 2017; 25:861-867. [PMID: 28951671 PMCID: PMC5605945 DOI: 10.1016/j.jsps.2016.12.008] [Citation(s) in RCA: 62] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2016] [Accepted: 12/26/2016] [Indexed: 11/22/2022] Open
Abstract
The aim of the present study was to determine the effect of different cryoprotectants and their concentration on the physicochemical characteristics of chitosan nanoparticles (CS-NPs). The effect of coating of CS-NPs with hyaluronic acid (HA) and alginic acid (ALG) before and after lyophilization was also evaluated. The ionic gelation method was used for the preparation of NPs and six different types of cryoprotectants (sucrose, glucose, trehalose, mannitol, polyethylene glycol-2000, and polyethylene glycol-10,000) were investigated at 5%, 10%, 20%, and 50% concentration levels. Coating of CS-NPs with HA and their protection with high amount of cryoprotectants indicated better particle size stability. Samples that were lyophilized without cryoprotectants resulted in an increase in average size due to high agglomeration. All cryoprotectants with varying amount provided some sort of size stability for the NPs except for the PEG-10,000 which had no protective effect at higher concentrations. Sucrose and trehalose sugars were found to have the highest protective effect with HA coated and uncoated CS-NPs. In conclusion, using cryoprotectants along with surface coating, the CS-NPs could achieve the desired physicochemical characteristics for a prolonged duration.
Collapse
Affiliation(s)
- Abdulaziz Almalik
- Life Science and Environment Research Institute, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia
| | - Ibrahim Alradwan
- Life Science and Environment Research Institute, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia
| | - Mohd Abul Kalam
- Nanomedicine Research Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box: 2457, Riyadh 11451, Saudi Arabia
| | - Aws Alshamsan
- Life Science and Environment Research Institute, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia.,Nanomedicine Research Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box: 2457, Riyadh 11451, Saudi Arabia.,King Abdullah Institute for Nanotechnology, King Saud University, P.O. Box: 2455, Riyadh 11451, Saudi Arabia
| |
Collapse
|
37
|
del Pozo-Rodríguez A, Solinís MÁ, Rodríguez-Gascón A. Applications of lipid nanoparticles in gene therapy. Eur J Pharm Biopharm 2016; 109:184-193. [DOI: 10.1016/j.ejpb.2016.10.016] [Citation(s) in RCA: 66] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2016] [Revised: 08/29/2016] [Accepted: 10/23/2016] [Indexed: 11/17/2022]
|
38
|
Montanari E, Gennari A, Pelliccia M, Gourmel C, Lallana E, Matricardi P, McBain AJ, Tirelli N. Hyaluronan/Tannic Acid Nanoparticles Via Catechol/Boronate Complexation as a Smart Antibacterial System. Macromol Biosci 2016; 16:1815-1823. [DOI: 10.1002/mabi.201600311] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2016] [Revised: 09/03/2016] [Indexed: 01/26/2023]
Affiliation(s)
- Elita Montanari
- NorthWest Centre of Advanced Drug Delivery (NoWCADD); Division of Pharmacy and Optometry; School of Health Sciences; Faculty of Biology; Medicine and Health; The University of Manchester; Manchester M13 9PT UK
- Department of Drug Chemistry and Technologies; Sapienza University of Rome; Piazzale Aldo Moro 5 00185 Rome Italy
| | - Arianna Gennari
- NorthWest Centre of Advanced Drug Delivery (NoWCADD); Division of Pharmacy and Optometry; School of Health Sciences; Faculty of Biology; Medicine and Health; The University of Manchester; Manchester M13 9PT UK
| | - Maria Pelliccia
- NorthWest Centre of Advanced Drug Delivery (NoWCADD); Division of Pharmacy and Optometry; School of Health Sciences; Faculty of Biology; Medicine and Health; The University of Manchester; Manchester M13 9PT UK
| | - Charlotte Gourmel
- NorthWest Centre of Advanced Drug Delivery (NoWCADD); Division of Pharmacy and Optometry; School of Health Sciences; Faculty of Biology; Medicine and Health; The University of Manchester; Manchester M13 9PT UK
| | - Enrique Lallana
- NorthWest Centre of Advanced Drug Delivery (NoWCADD); Division of Pharmacy and Optometry; School of Health Sciences; Faculty of Biology; Medicine and Health; The University of Manchester; Manchester M13 9PT UK
| | - Pietro Matricardi
- Department of Drug Chemistry and Technologies; Sapienza University of Rome; Piazzale Aldo Moro 5 00185 Rome Italy
| | - Andrew J. McBain
- Division of Pharmacy and Optometry; School of Health Sciences; Faculty of Biology; Medicine and Health; The University of Manchester; Manchester M13 9PT UK
| | - Nicola Tirelli
- NorthWest Centre of Advanced Drug Delivery (NoWCADD); Division of Pharmacy and Optometry; School of Health Sciences; Faculty of Biology; Medicine and Health; The University of Manchester; Manchester M13 9PT UK
| |
Collapse
|
39
|
Kalam MA. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Int J Biol Macromol 2016; 89:127-36. [DOI: 10.1016/j.ijbiomac.2016.04.070] [Citation(s) in RCA: 97] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2016] [Revised: 04/17/2016] [Accepted: 04/22/2016] [Indexed: 11/28/2022]
|
40
|
Gennari A, Pelliccia M, Donno R, Kimber I, Tirelli N. Mannosylation Allows for Synergic (CD44/C-Type Lectin) Uptake of Hyaluronic Acid Nanoparticles in Dendritic Cells, but Only upon Correct Ligand Presentation. Adv Healthc Mater 2016; 5:966-76. [PMID: 26865006 DOI: 10.1002/adhm.201500941] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2015] [Revised: 12/31/2015] [Indexed: 12/17/2022]
Abstract
The selective targeting of dendritic cells (DCs) can lead to more efficacious vaccines. Here, materials have been designed for a synergic DC targeting: interacting with CD44 through the use of hyaluronic acid (HA), and with mannose-binding lectins (typical DC pattern recognition receptors) through HA mannosylation. Negatively charged, HA-displaying nanoparticles are produced via polyelectrolyte complexation of (mannosylated) HA and high- or low- molecular-weight chitosan (CS, 36 and 656 kDa). Using CS36, HA is better exposed and the particles have a higher affinity for HA receptors; this means a higher number of receptors clustered around each particle and, due to the rather limited CD44 availability, an overall lower uptake per cell. Employing Langerhans-like XS106 cells, all particles show negligible toxicity or inflammatory activation. The cellular uptake kinetics are qualitatively similar to other leukocytic models and thus considered to be CD44-dominated; the uptake increases with increasing HA mannosylation and with the use of adjuvants (LPS, mannan) for CS36/HA but not for CS656//HA particles; this indicates that the interactions with mannose-binding receptors requires a correct ligand presentation, and only in that case can they be enhanced by appropriate adjuvants. In summary, mannose-binding receptors can be used to enhance the internalization of HA-based carriers, although this positive synergy depends on the mode of ligand presentation.
Collapse
Affiliation(s)
- Arianna Gennari
- Centre for Tissue Injury and Repair; Institute of Inflammation and Repair; Faculty of Medical and Human Sciences; The University of Manchester; Manchester M13 9PT UK
| | - Maria Pelliccia
- Centre for Tissue Injury and Repair; Institute of Inflammation and Repair; Faculty of Medical and Human Sciences; The University of Manchester; Manchester M13 9PT UK
| | - Roberto Donno
- NorthWest Centre of Advanced Drug Delivery (NoWCADD); Manchester Pharmacy School; Faculty of Medical and Human Sciences; The University of Manchester; Manchester M13 9PT UK
| | - Ian Kimber
- Faculty of Life Sciences; The University of Manchester; Manchester M13 9PT UK
| | - Nicola Tirelli
- Centre for Tissue Injury and Repair; Institute of Inflammation and Repair; Faculty of Medical and Human Sciences; The University of Manchester; Manchester M13 9PT UK
- NorthWest Centre of Advanced Drug Delivery (NoWCADD); Manchester Pharmacy School; Faculty of Medical and Human Sciences; The University of Manchester; Manchester M13 9PT UK
| |
Collapse
|
41
|
Badwaik V, Liu L, Gunasekera D, Kulkarni A, Thompson DH. Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells. Mol Pharm 2016; 13:1176-84. [PMID: 26900622 DOI: 10.1021/acs.molpharmaceut.6b00078] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Targeted delivery is a key element for improving the efficiency and safety of nonviral vectors for gene therapy. We have recently developed a CD44 receptor targeted, hyaluronic acid-adamantamethamidyl based pendant polymer system (HA-Ad), capable of forming complexes with cationic β-cyclodextrins (CD-PEI(+)) and pDNA. Complexes formed using these compounds (HA-Ad:CD-PEI(+):pDNA) display high water solubility, good transfection efficiency, and low cytotoxicity. Spatial and dynamic tracking of the transfection complexes by confocal microscopy and multicolor flow cytometry techniques was used to evaluate the target specificity, subcellular localization, and endosomal escape process. Our data shows that cells expressing the CD44 receptor undergo enhanced cellular uptake and transfection efficiency with HA-Ad:CD-PEI(+):pDNA complexes. This transfection system, comprised noncovalent assembly of cyclodextrin:adamantamethamidyl-modified hyaluronic acid via host:guest interactions to condense pDNA, is a potentially useful tool for targeted delivery of nucleic acid therapeutics.
Collapse
Affiliation(s)
- Vivek Badwaik
- Department of Chemistry and Purdue University Center for Cancer Research, Multidisciplinary Cancer Research Facility, Bindley Bioscience Center, Purdue University , 1203 West State Street, West Lafayette, Indiana 47907, United States
| | - Linjia Liu
- Department of Chemistry and Purdue University Center for Cancer Research, Multidisciplinary Cancer Research Facility, Bindley Bioscience Center, Purdue University , 1203 West State Street, West Lafayette, Indiana 47907, United States
| | - Dinara Gunasekera
- Department of Chemistry and Purdue University Center for Cancer Research, Multidisciplinary Cancer Research Facility, Bindley Bioscience Center, Purdue University , 1203 West State Street, West Lafayette, Indiana 47907, United States
| | - Aditya Kulkarni
- Department of Chemistry and Purdue University Center for Cancer Research, Multidisciplinary Cancer Research Facility, Bindley Bioscience Center, Purdue University , 1203 West State Street, West Lafayette, Indiana 47907, United States
| | - David H Thompson
- Department of Chemistry and Purdue University Center for Cancer Research, Multidisciplinary Cancer Research Facility, Bindley Bioscience Center, Purdue University , 1203 West State Street, West Lafayette, Indiana 47907, United States
| |
Collapse
|
42
|
Quagliariello V, Armenia E, Aurilio C, Rosso F, Clemente O, de Sena G, Barbarisi M, Barbarisi A. New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase. J Cell Physiol 2016; 231:1784-95. [DOI: 10.1002/jcp.25283] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2015] [Accepted: 12/09/2015] [Indexed: 12/11/2022]
Affiliation(s)
- Vincenzo Quagliariello
- Department of Anaesthesological, Surgical and Emergency Sciences; Second University of Naples; Naples Italy
| | - Emilia Armenia
- Department of Anaesthesological, Surgical and Emergency Sciences; Second University of Naples; Naples Italy
| | - Caterina Aurilio
- Department of Anaesthesological, Surgical and Emergency Sciences; Second University of Naples; Naples Italy
| | - Francesco Rosso
- Department of Anaesthesological, Surgical and Emergency Sciences; Second University of Naples; Naples Italy
| | - Ottavia Clemente
- Department of Anaesthesological, Surgical and Emergency Sciences; Second University of Naples; Naples Italy
| | - Gabriele de Sena
- Department of Anaesthesological, Surgical and Emergency Sciences; Second University of Naples; Naples Italy
| | - Manlio Barbarisi
- Department of Medical, Surgical, Neurological, Metabolic, and Aging Sciences; Second University of Naples; Naples Italy
| | - Alfonso Barbarisi
- Department of Anaesthesological, Surgical and Emergency Sciences; Second University of Naples; Naples Italy
| |
Collapse
|
43
|
Fortier C, Louvier E, Durocher Y, De Crescenzo G. Tailoring the Surface of a Gene Delivery Vector with Carboxymethylated Dextran: A Systematic Analysis. Biomacromolecules 2015; 16:1671-81. [DOI: 10.1021/acs.biomac.5b00221] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Charles Fortier
- Department
of Chemical Engineering, Groupe de Recherche en Sciences et Technologies
Biomédicales (GRSTB), École Polytechnique de Montréal, P.O.
Box 6079, succ. Centre-Ville, Montreal (QC), Canada H3C 3A7
- Life Sciences
- NRC Human Health Therapeutics Portfolio, Building Montreal-Royalmount,
National Research Council Canada, Montreal (QC), Canada H4P 2R2
| | - Elodie Louvier
- Life Sciences
- NRC Human Health Therapeutics Portfolio, Building Montreal-Royalmount,
National Research Council Canada, Montreal (QC), Canada H4P 2R2
- Département
de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal (QC), Canada H3C 3J7
| | - Yves Durocher
- Life Sciences
- NRC Human Health Therapeutics Portfolio, Building Montreal-Royalmount,
National Research Council Canada, Montreal (QC), Canada H4P 2R2
- Département
de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal (QC), Canada H3C 3J7
| | - Gregory De Crescenzo
- Department
of Chemical Engineering, Groupe de Recherche en Sciences et Technologies
Biomédicales (GRSTB), École Polytechnique de Montréal, P.O.
Box 6079, succ. Centre-Ville, Montreal (QC), Canada H3C 3A7
| |
Collapse
|
44
|
Jordan AR, Racine RR, Hennig MJP, Lokeshwar VB. The Role of CD44 in Disease Pathophysiology and Targeted Treatment. Front Immunol 2015; 6:182. [PMID: 25954275 PMCID: PMC4404944 DOI: 10.3389/fimmu.2015.00182] [Citation(s) in RCA: 177] [Impact Index Per Article: 19.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2015] [Accepted: 04/02/2015] [Indexed: 12/17/2022] Open
Abstract
The cell-surface glycoprotein CD44 is involved in a multitude of important physiological functions including cell proliferation, adhesion, migration, hematopoiesis, and lymphocyte activation. The diverse physiological activity of CD44 is manifested in the pathology of a number of diseases including cancer, arthritis, bacterial and viral infections, interstitial lung disease, vascular disease, and wound healing. This diversity in biological activity is conferred by both a variety of distinct CD44 isoforms generated through complex alternative splicing, posttranslational modifications (e.g., N- and O-glycosylation), interactions with a number of different ligands, and the abundance and spatial distribution of CD44 on the cell surface. The extracellular matrix glycosaminoglycan hyaluronic acid (HA) is the principle ligand of CD44. This review focuses both CD44-hyaluronan dependent and independent CD44 signaling and the role of CD44–HA interaction in various pathophysiologies. The review also discusses recent advances in novel treatment strategies that exploit the CD44–HA interaction either for direct targeting or for drug delivery.
Collapse
Affiliation(s)
- Andre R Jordan
- Sheila and David Fuente Program in Cancer Biology, University of Miami-Miller School of Medicine , Miami, FL , USA
| | - Ronny R Racine
- Department of Urology, University of Miami-Miller School of Medicine , Miami, FL , USA
| | - Martin J P Hennig
- Department of Urology, University of Miami-Miller School of Medicine , Miami, FL , USA ; Department of Urology and Uro-oncology, Hannover Medical School , Hannover , Germany
| | - Vinata B Lokeshwar
- Department of Urology, University of Miami-Miller School of Medicine , Miami, FL , USA ; Department of Cell Biology, University of Miami-Miller School of Medicine , Miami, FL , USA ; Miami Clinical Translational Institute, University of Miami-Miller School of Medicine , Miami, FL , USA
| |
Collapse
|
45
|
Nanoparticle delivery of stable miR-199a-5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway. Biomaterials 2015; 53:239-50. [PMID: 25890723 DOI: 10.1016/j.biomaterials.2015.02.071] [Citation(s) in RCA: 89] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2014] [Revised: 02/10/2015] [Accepted: 02/15/2015] [Indexed: 12/22/2022]
Abstract
Elucidating the regulatory mechanisms of osteogenesis of human mesenchymal stem cell (hMSC) is important for the development of cell therapies for bone loss and regeneration. Here we showed that hsa-miR-199a-5p modulated osteogenic differentiation of hMSCs at both early and late stages through HIF1a pathway. hsa-miR-199a expression was up-regulated during osteogenesis for both of two mature forms, miR-199a-5p and -3p. Over-expression of miR-199a-5p but not -3p enhanced differentiation of hMSCs in vitro, whereas inhibition of miR-199a-5p reduced the expression of osteoblast-specific genes, alkaline phosphatase (ALP) activity, and mineralization. Furthermore, over-expression of miR-199a enhanced ectopic bone formation in vivo. Chitosan nanoparticles were used for delivery of stable modified hsa-miR-199a-5p (agomir) both in vitro and in vivo, as a proof-of-concept for stable agomir delivery on bone regeneration. The hsa-mir199a-5p agomir were mixed with Chitosan nanoparticles to form nanoparticle/hsa-mir199a-5p agomir plasmid (nanoparticle/agomir) complexes, and nanoparticle/agomir complexes could improve the in vivo regeneration of bone. Further mechanism studies revealed that hypoxia enhanced osteogenesis at early stage and inhibited osteogenesis maturation at late stage through HIF1a-Twist1 pathway. At early stage of differentiation, hypoxia induced HIF1a-Twist1 pathway to enhance osteogenesis by up-regulating miR-199a-5p, while at late stage of differentiation, miR-199a-5p enhanced osteogenesis maturation by inhibiting HIF1α-Twist1 pathway.
Collapse
|
46
|
Zhu XS, Lin ZY, Du J, Cao GX, Liu G. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia. Asian Pac J Cancer Prev 2015; 15:4773-80. [PMID: 24998540 DOI: 10.7314/apjcp.2014.15.12.4773] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND To investigate the effects of small interference RNA (siRNA) targeting BCR/ABL mRNA on proliferation and apoptosis in the K562 human chronic myeloid leukemia (CML) cell line and to provide a theoretical rationale and experimental evidence for its potential clinical application for anti-CML treatment. MATERIALS AND METHODS The gene sequence for BCR/ABL mRNA was found from the GeneBank. The target gene site on the BCR/ABL mRNA were selected according to Max-Planck-Institute (MPI) and rational siRNA design rules, the secondary structure of the candidate targeted mRNA was predicted, the relevant thermodynamic parameters were analyzed, and the targeted gene sequences were compared with BLAST to eliminate any sequences with significant homology. Inhibition of proliferation was evaluated by MTT assay and colony-formation inhibiting test. Apoptosis was determined by flow cytometry (FCM) and the morphology of apoptotic cells was identified by Giemsa-Wright staining. Western blotting was used to analyze the expression of BCR/ABL fusion protein in K562 cells after siRNA treatment. RESULTS The mRNA local secondary structure calculated by RNA structure software, and the optimal design of specific siRNA were contributed by bioinformatics rules. Five sequences of BCR/ABL siRNAs were designed and synthesized in vitro. Three sequences, siRNA1384, siRNA1276 and siRNA1786, which showed the most effective inhibition of K562 cell growth, were identified among the five candidate siRNAs, with a cell proliferative inhibitory rate nearly 50% after exposure to 12.5 nmol/L~50 nmol/L siRNA1384 for 24,48 and 72 hours. The 50% inhibitory concentrations (IC50) of siRNA1384, siRNA1276 and siRNA1786 for 24 hours were 46.6 nmol/L, 59.3 nmol/L and 62.6 nmol/L, respectively, and 65.668 nmol/L, 76.6 nmol/L, 74.4 nmol/L for 72 hours. The colony-formation inhibiting test also indicated that, compared with control, cell growth of siRNA treated group was inhibited. FCM results showed that the rate of cell apoptosis increased 24 hours after transfecting siRNA. The results of annexinV/PI staining indicated that the rate of apoptosis imcreased (1.53%, 15.3%, 64.5%, 57.5% and 21.5%) following treamtne with siRNAs (siRNA34, siRNA372, siRNA1384, siRNA1276 and siRNA1786). Morphological analysis showed td typical morphologic changes of apoptosis such as shrunken, fragmentation nucleus as well as "apoptotic bodies" after K562 cell exposure to siRNA. Western blot analysis showed that BCR/ABL protein was reduced sharply after a single dose of 50 nmol/L siRNA transfection. CONCLUSIONS Proliferation of K562 cells was remarkbly inhibited by siRNAs (siRNA1384, siRNA1276 and siRNA1786) in a concentration-dependent manner in vitro, with effective induction of apoptosis at a concentration of 50 nmol/L. One anti-leukemia mechanism in K562 cells appeared that BCR/ABL targeted protein was highly down-regulated. The siRNAs (siRNA1384, siRNA1276 and siRNA1786) may prove valuable in the treatment of CML.
Collapse
Affiliation(s)
- Xi-Shan Zhu
- Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang, China E-mail :
| | | | | | | | | |
Collapse
|
47
|
Kurosaki T, Nakasone C, Kodama Y, Egashira K, Harasawa H, Muro T, Nakagawa H, Kitahara T, Higuchi N, Nakamura T, Sasaki H. Splenic Gene Delivery System Using Self-assembling Nano-complex with Phosphatidylserine Analog. Biol Pharm Bull 2015; 38:23-9. [DOI: 10.1248/bpb.b14-00478] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
| | | | - Yukinobu Kodama
- Department of Hospital Pharmacy, Nagasaki University Hospital
| | - Kanoko Egashira
- Department of Hospital Pharmacy, Nagasaki University Hospital
| | - Hitomi Harasawa
- Department of Hospital Pharmacy, Nagasaki University Hospital
| | - Takahiro Muro
- Department of Hospital Pharmacy, Nagasaki University Hospital
| | - Hiroo Nakagawa
- Department of Hospital Pharmacy, Nagasaki University Hospital
| | | | | | | | - Hitoshi Sasaki
- Department of Hospital Pharmacy, Nagasaki University Hospital
| |
Collapse
|
48
|
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia. MOLECULAR THERAPY. NUCLEIC ACIDS 2015; 4:e240. [DOI: 10.1038/mtna.2015.13] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2015] [Accepted: 03/26/2015] [Indexed: 02/08/2023]
|
49
|
Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma. Int J Biol Macromol 2015; 72:569-74. [DOI: 10.1016/j.ijbiomac.2014.09.005] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2014] [Revised: 08/29/2014] [Accepted: 09/08/2014] [Indexed: 11/21/2022]
|
50
|
Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference. Int J Pharm 2014; 479:181-8. [PMID: 25542984 DOI: 10.1016/j.ijpharm.2014.12.047] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2014] [Revised: 12/17/2014] [Accepted: 12/19/2014] [Indexed: 02/02/2023]
Abstract
RNA interference (RNAi) is a promising strategy to treat the chronic infection by hepatitis C virus (HCV). The objective of this work was to develop a non-viral vector based on solid lipid nanoparticles (SLN) and RNAi to inhibit the internal ribosome entry site (IRES) mechanism of the HCV. The vectors were prepared with SLN, protamine, hylauronic acid (HA) or dextran (DX), and a short-hairpin RNA expression plasmid targeted to the stem loop II of the 5' UTR (shRNA74). The particle size, surface charge, and capacity to bind, release and protect the shRNA74 against nucleases were evaluated. Cell uptake, silencing capacity and cell viability were evaluated in HepG2 cells. All the vectors presented particle size in the range of nanometers and positive surface charge, and they were able to protect the shRNA74 against DNase. An effective and rapid uptake into the cells was observed. Silencing capacity ranged from 3% to 67% depending on the presence of DX or HA in the vector, the shRNA74 to SLN ratio, and the shRNA74 dose. Vectors prepared with HA showed to be twice more effective than those prepared with DX. Differences in the intracellular trafficking may justify the higher efficacy of the HA-prepared vectors.
Collapse
|